Annual Total Long Term Liabilities
$697.70 K
-$31.55 M-97.84%
December 31, 2023
Summary
- As of February 24, 2025, CTCX annual total long term liabilities is $697.70 thousand, with the most recent change of -$31.55 million (-97.84%) on December 31, 2023.
- During the last 3 years, CTCX annual total long term liabilities has fallen by -$14.63 million (-95.45%).
- CTCX annual total long term liabilities is now -97.84% below its all-time high of $32.24 million, reached on December 31, 2022.
Performance
CTCX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$332.60 K
-$295.30 K-47.03%
September 30, 2024
Summary
- As of February 24, 2025, CTCX quarterly total long term liabilities is $332.60 thousand, with the most recent change of -$295.30 thousand (-47.03%) on September 30, 2024.
- Over the past year, CTCX quarterly long term liabilities has stayed the same.
- CTCX quarterly long term liabilities is now -98.97% below its all-time high of $32.24 million, reached on December 31, 2022.
Performance
CTCX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
CTCX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -97.8% | 0.0% |
| 3 y3 years | -95.5% | -99.0% |
| 5 y5 years | -95.5% | -99.0% |
CTCX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -97.8% | at low | -99.0% | -100.0% |
| 5 y | 5-year | -97.8% | at low | -99.0% | -100.0% |
| alltime | all time | -97.8% | at low | -99.0% | -100.0% |
Carmell Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $332.60 K(-47.0%) |
| Jun 2024 | - | $627.90 K(-5.8%) |
| Mar 2024 | - | $666.40 K(-4.5%) |
| Dec 2023 | $697.70 K | $697.70 K(-97.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $23.60 M(>+9900.0%) |
| Jun 2023 | - | $0.00(-100.0%) |
| Dec 2022 | $32.24 M(+110.3%) | $32.24 M |
| Dec 2021 | $15.33 M | - |
FAQ
- What is Carmell Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Carmell Therapeutics?
- What is Carmell Therapeutics annual total long term liabilities year-on-year change?
- What is Carmell Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Carmell Therapeutics?
- What is Carmell Therapeutics quarterly long term liabilities year-on-year change?
What is Carmell Therapeutics annual total long term liabilities?
The current annual total long term liabilities of CTCX is $697.70 K
What is the all time high annual total long term liabilities for Carmell Therapeutics?
Carmell Therapeutics all-time high annual total long term liabilities is $32.24 M
What is Carmell Therapeutics annual total long term liabilities year-on-year change?
Over the past year, CTCX annual total long term liabilities has changed by -$31.55 M (-97.84%)
What is Carmell Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of CTCX is $332.60 K
What is the all time high quarterly long term liabilities for Carmell Therapeutics?
Carmell Therapeutics all-time high quarterly total long term liabilities is $32.24 M
What is Carmell Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, CTCX quarterly total long term liabilities has changed by $0.00 (0.00%)